- Home
- ERAS vs VHI Comparison
ERAS vs VHI Comparison
Compare ERAS & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- VHI
- Stock Information
- Founded
- ERAS 2018
- VHI 1932
- Country
- ERAS United States
- VHI United States
- Employees
- ERAS N/A
- VHI N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- ERAS Health Care
- VHI Industrials
- Exchange
- ERAS Nasdaq
- VHI Nasdaq
- Market Cap
- ERAS 439.7M
- VHI 454.3M
- IPO Year
- ERAS 2021
- VHI N/A
- Fundamental
- Price
- ERAS $1.71
- VHI $16.11
- Analyst Decision
- ERAS Buy
- VHI Sell
- Analyst Count
- ERAS 6
- VHI 1
- Target Price
- ERAS $3.83
- VHI $12.00
- AVG Volume (30 Days)
- ERAS 964.1K
- VHI 10.5K
- Earning Date
- ERAS 11-11-2025
- VHI 11-06-2025
- Dividend Yield
- ERAS N/A
- VHI 1.97%
- EPS Growth
- ERAS N/A
- VHI 269.89
- EPS
- ERAS N/A
- VHI 3.44
- Revenue
- ERAS N/A
- VHI $2,093,500,000.00
- Revenue This Year
- ERAS N/A
- VHI $22.20
- Revenue Next Year
- ERAS N/A
- VHI $7.66
- P/E Ratio
- ERAS N/A
- VHI $4.67
- Revenue Growth
- ERAS N/A
- VHI 4.04
- 52 Week Low
- ERAS $1.01
- VHI $14.10
- 52 Week High
- ERAS $3.31
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- ERAS 59.36
- VHI 51.19
- Support Level
- ERAS $1.53
- VHI N/A
- Resistance Level
- ERAS $1.69
- VHI $16.96
- Average True Range (ATR)
- ERAS 0.10
- VHI 0.50
- MACD
- ERAS 0.01
- VHI -0.60
- Stochastic Oscillator
- ERAS 96.20
- VHI 93.94
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.